NEUREN PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.27 AUD | -6.33% |
|
-2.12% | -18.82% |
| 05-28 | Transcript : Neuren Pharmaceuticals Limited - Shareholder/Analyst Call | |
| 05-27 | Neuren Phase 2 Trial Shows Significant Improvements in Pitt Hopkins Syndrome | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Other Pharmaceuticals | -6.33% | -2.12% | -18.82% | +49.82% | +1,568.31% | 1.83B |  |  | |
- Stock Market
- Equities
- NEU Stock
- Charts Neuren Pharmaceuticals Limited
- Relative Strength Chart